U.S. pharma big copyright scrapped two experimental weight loss products last year—a the moment-daily tablet, lotiglipron, resulting from elevated liver enzymes and also a 2 times-every day pill, danuglipron, on account of sturdy Unwanted side effects—but CEO Albert Bourla has explai